Metabolic syndrome in women of childbearing age and pregnancy: Recognition and management of dyslipidemia

Metabolic Syndrome and Related Disorders

Volumn 3, Issue 3, 2005, Pages 250-258

  Paramsothy, Pathmaja ^a   Knopp, Robert H ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BILE ACID; COLESEVELAM; ESTROGEN; EZETIMIBE; FIBRIC ACID DERIVATIVE; FISH OIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEDIUM CHAIN TRIACYLGLYCEROL; METFORMIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PHYTOSTEROL; PROGESTERONE; TRIACYLGLYCEROL; TROGLITAZONE;

BEHAVIOR THERAPY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LABOR COMPLICATION; LOW DRUG DOSE; META ANALYSIS; METABOLIC SYNDROME X; OBESITY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 27744512172     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2005.3.250     Document Type: Review

References (46)

1. Park Y, Zhu S, Heymsfield S, et al, The metabolic syndrome: prevalence and associated risk factor findings in the U.S. population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436.
2. Apridonidze T, Essah P, Nestler JE, et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-1935.
3. Knopp RH, Retzlaff B, Kahn SE, et al. Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol 2003;23:1437-1443.
4. Wyszynski D, Watherworth D, Grundy SM, et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III Definition of Metabolic Syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 2005;95:194-198.
5. Andersen P, Seljeflot I, Birkeland K, et al. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism 1995;44:611-616.
6. Dansinger ML, Gleason JA, Schaefer EJ, et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction. JAMA 2005;293:43-53.
7. Foster GD, Wyatt HR, Klein S, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2004;348:2082-2090.
8. Walden CE, Retzlaff BM, Knopp RH, et al. Differential effect of National Cholesterol Education Program (NCEP) Step II Diet on HDL cholesterol, its subfractions, and apoprotein A-I levels in hypercholesterolemic women and men after 1 year: The beFIT Study.Arterioscler Thromb Vasc Biol 2000;20:1580-1587.
9. Moran L, Norman RJ. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:719-736.
10. Lord JM, Flight IHK, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003;327:951-956.
11. Legro RS, Azziz R, Ghazzi MN, et al. Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab 2003;88:5137-5144.
12. Pasquall R, Gambineri A, Anconetani B, et al. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term estrogen-progesterone treatment. Clin Endocrinol 1999;50:517-527.
13. Alexander C, Haffner S. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-1214.
14. Turhan H, Yasar AS, Yetkin E, et al. High prevalence of metabolic syndrome among young women with premature coronary artery disease. Coron Artery Dis 2004;16:37-40.
15. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detaction evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3121.
16. Grundy SM, Cleeman JI, Stone NJ, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004;44:720-732.
17. Edison RJ, Muenke M. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet 2004;131A:287-298.
18. Spencer FA, Fonarow GC, French W, et al. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction. Arch Intern Med 2004;164:2162-2168.
19. Knopp RH, Drug treatment of lipid disorders. N Engl J Med 1999;341:498-511.
20. Pouta A, Hartikainen A, Jarvelin M, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 2004;43:825-831.
21. Verma A, Boney CM, Vohr B, Insulin resistancy syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002;87:3227-3235.
22. Knopp RH, Bartolome B, Zhu X. The principles of perinatal-neonatal metabolism. In: Cowett RM, ed. Lipid Metabolism in Pregnancy, 2nd ed. New York: Springer, 1998:221-258.
23. Knopp RH, Ruder HJ, Herrera E, et al. Carbohydrate metabolism in pregnancy. VII. Insulin tolerance during later pregnancy in the fed and fasted pregnant rat. Acta Endocrinol 1970;65:352-360.
24. Buchanan TA, Metzger BE, Freinkel N, et al. Insulin sensitivity and b-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990;162:1008-1014.
25. Knopp RH, Montes A, Warth MR. Biphasic metabolic control of hypertriglyceridemia in pregnancy. Clin Res 1977;25:161A.
26. Silliman K, Shore V, Forte TM. Hypertriglyceridemia during late pregnancy is associated with the formation of small dense low-density lipoproteins and the presence of large buoyant high-density lipoproteins. Metabolism 1994;43:1035-1041.
27. Alvarez JJ, Montelongo A, Ilgesias A, et al. Longitudinal study on lipoprotein profile, high density lipoprotein subclass and postheparin lipases during gestation in women. J Lipid Res 1996;37:299-308.
28. Desoye G, Schweditsch MO, Pfeiffer KP, et al. Correlation of hormones with lipid and lipoprotein levels during pregnancy and postpartum. J Clin Endocrinol Metab 1987;64:704-712.
29. Manten GTR, Franx A, van der Hoek YY, et al. Changes of plasma lipoprotein(a) during and after normal pregnancy in Caucasians. J Matern Fetal Neonatal Med 2003;14:91-95.
30. Belo L, Caslake M, Rebelo I, et al. LDL size, total antioxidant status and oxidized LDL in normal human pregnancy: a longitudinal study. Atherosclerosis 2004; 177:391-399.
31. Solomon CG, Seely EW. Hypertension in pregnancy - a manifestation of the insulin resistance syndrome? Hypertension 2001;37:232-239.
32. Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129, 290 births. Lancet 2001;357:2002-2006.
33. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997;77:154-158.
34. Wilson BJ, Watson MS, Smith WCS, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326:845-851.
35. Lorentzen B, Endersen MJ, Clausen T, et al. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypetens Pregnancy 1994;13:103-109.
36. Enquobahrie DA, Williams MA, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004;17:574-581.
37. Sattar N, Bendomir A, Berry C, et al. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997; 89:403-408.
38. Ogura K, Miyatake T, Yoshnino G, et al. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb 2002;9:42-47.
39. Davis CL, Gutt M, Skyler JS, et al. History of gestational diabetes, insulin resistance and coronary risk. J Diabetes Complications 1999;13:216-223.
40. Clark CM, Qui C, Golichowski A, et al. Gestational diabetes: should it be added to the syndrome of insulin resistance. Diabetes Care 1997;20:867-871.
41. Ramsay JE, Ferrell WR, Sattar N, et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87:4231-4237.
42. Villar J, Merialdi M, de Onis M, et al. Characteristics of randomized controlled trials included in systematic reviews of nutritional interventions reporting maternal morbidity, mortality, preterm delivery, intra-uterine growth restriction, and small for gestational age and birth weight outcomes. J Nutr 2003; 133:1632S-1639S.
43. Villar J, Merialdi M, de Oni M, et al. Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery: an overview of randomized controlled trials. J Nutr 2003;133:1606S-1625S.
44. Knopp RH, Walden CE, Albers JJ. Effect of postpartum lactation on lipoprotein lipids and apoproteins. J Clin Endocrinol Metab 1985;60:542-547.
45. Marroquin OC, Kip KE, Reis SE, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women. Circulation 2004;109:714-721.
46. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 7th Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560-2572.